Delay and survival in bladder cancer
- PMID: 12010230
- DOI: 10.1046/j.1464-410x.2002.02776.x
Delay and survival in bladder cancer
Abstract
Objective: To assess in detail and evaluate the effect on survival of delays in the diagnosis and treatment of cancer (which might lead to a worse prognosis), dividing the delay from onset of symptoms to first treatment into several components, comprising patient delay, general practitioner (GP) delay, and two or more periods of hospital delay.
Patients and methods: Data were prospectively collected on 1537 new cases of urothelial cancer in the West Midlands from 1 January 1991 to 30 June 1992. Death information was obtained from the West Midlands Cancer Intelligence Unit and censored at 31 July 2000. The influence of delay times on survival was explored.
Results: The median delay from onset of symptoms to GP referral was 14 days (Delay 1), from GP referral to first hospital attendance was 28 days (Delay 2), and from first hospital attendance to first transurethral resection of bladder tumour was 20 days (Delay 3). The median hospital delay (Delay 2 + 3) was 68 days and the median total delay (Delay 1 + 2 + 3) was 110 days. Patients with a shorter Delay 1 had a lower tumour stage and a 5% better 5-year survival. Patients with a shorter hospital delay had worse survival; total delay had no effect on survival.
Conclusions: There was significantly better survival for patients referred to hospital within 14 days of the onset of symptoms. The relationship between delay and survival in bladder cancer is complex. Hospital delays may be influenced more by comorbidity than by the characteristics of the tumour. However, the adverse effects of delay seem to be most pronounced for patients with pT1 tumours.
Similar articles
-
Delays in the diagnosis and treatment of lung cancer.Chest. 2005 Oct;128(4):2282-8. doi: 10.1378/chest.128.4.2282. Chest. 2005. PMID: 16236885
-
Time lag to diagnosis of bladder cancer--influence of psychosocial parameters and level of health-care provision.Scand J Urol Nephrol. 1993;27(3):363-9. doi: 10.3109/00365599309180448. Scand J Urol Nephrol. 1993. PMID: 8290917
-
Socio-economic deprivation and survival in bladder cancer.BJU Int. 2004 Sep;94(4):539-43. doi: 10.1111/j.1464-410X.2004.04997.x. BJU Int. 2004. PMID: 15329108
-
Does prolonging the time to bladder cancer surgery affect long-term cancer control: a systematic review of the literature.Can J Urol. 2006 Jun;13 Suppl 3:37-47. Can J Urol. 2006. PMID: 16818011 Review.
-
Delay in the surgical treatment of bladder cancer and survival: systematic review of the literature.Eur Urol. 2006 Dec;50(6):1176-82. doi: 10.1016/j.eururo.2006.05.046. Epub 2006 Jun 13. Eur Urol. 2006. PMID: 16846680 Review.
Cited by
-
Rationale for an early detection program for bladder cancer.Indian J Urol. 2011 Apr;27(2):218-25. doi: 10.4103/0970-1591.82841. Indian J Urol. 2011. PMID: 21814313 Free PMC article.
-
Cell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomena.Philos Trans R Soc Lond B Biol Sci. 2015 Feb 5;370(1661):20140042. doi: 10.1098/rstb.2014.0042. Philos Trans R Soc Lond B Biol Sci. 2015. PMID: 25533099 Free PMC article. Review.
-
Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer.World J Urol. 2012 Dec;30(6):847-52. doi: 10.1007/s00345-012-0979-x. Epub 2012 Nov 5. World J Urol. 2012. PMID: 23124847 Free PMC article.
-
The impact of the two-week wait rule on the diagnosis and management of bladder cancer in a single UK institution.Ann R Coll Surg Engl. 2010 Jan;92(1):46-50. doi: 10.1308/003588410X12518836440207. Ann R Coll Surg Engl. 2010. PMID: 20056061 Free PMC article.
-
Surgical Delay Is Associated with Improved Survival in Hepatocellular Carcinoma: Results of the National Cancer Database.J Gastrointest Surg. 2019 May;23(5):933-943. doi: 10.1007/s11605-018-3925-4. Epub 2018 Sep 4. J Gastrointest Surg. 2019. PMID: 30328070
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical